Original Article

International Journal of Obesity (2009) 33, 1007–1012; doi:10.1038/ijo.2009.136; published online 7 July 2009

Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver

H Quesada1,2, J M del Bas1,2, D Pajuelo1, S Díaz1, J Fernandez-Larrea1, M Pinent1, L Arola1, M J Salvadó1 and C Bladé1

1Departament de Bioquímica i Biotecnologia, Nutrigenomics Research Group, Universitat Rovira i Virgili, Tarragona, Spain

Correspondence: Dr MJ Salvadó, Departament de Bioquímica i Biotecnología, Universitat Rovira i Virgili. Marcel·lí Domingo s/n. 43007 Tarragona, Spain. E-mail: mariajosepa.salvado@urv.cat

2These authors have contributed equally to this work

Received 29 January 2009; Revised 7 May 2009; Accepted 30 May 2009; Published online 7 July 2009.





To determine whether proanthocyanidins can protect against dyslipidemia induced by a high-fat diet (HFD) and to address the mechanisms that underlie this hypolipidemic effect.

Design and measurements:


Female Wistar rats were fed on a HFD for 13 weeks. They were divided into two groups, one of which was treated with a grape seed proanthocyanidin extract (25mgkg−1 of body weight) for 10 days. Plasma and liver lipids were measured by colorimetric and gravimetric analysis. Liver, muscle and adipose tissue were used to study the expression of genes involved in the synthesis and oxidation of fatty acids and lipoprotein homeostasis by real-time RT-PCR.



The administration of proanthocyanidins normalized plasma triglyceride and LDL-cholesterol (both parameters significantly increased with the HFD) but tended to decrease hypercholesterolemia and fatty liver. Gene expression analyses revealed that proanthocyanidins repressed both the expression of hepatic key regulators of lipogenesis and very low density lipoprotein (VLDL) assembling such as SREBP1, MTP and DGAT2, all of which were overexpressed by the HFD.



These findings indicate that natural proanthocyanidins improve dyslipidemia associated with HFDs, mainly by repressing lipogenesis and VLDL assembly in the liver, and support the idea that they are powerful agents for preventing and treating lipid altered metabolic states.


high-fat diet, liver, proanthocyanidins, triglycerides, SREBP1, MTP



These links to content published by NPG are automatically generated


Dyslipidemia in type 2 diabetes mellitus

Nature Clinical Practice Endocrinology & Metabolism Review (01 Mar 2009)

Diacylglycerol: Efficacy and Mechanism of Action of an Anti-Obesity Agent **

Obesity Review

Diagnosis and treatment of apolipoprotein B dyslipoproteinemias

Nature Reviews Endocrinology Review (01 Jun 2010)

Extra navigation